A proof-of-concept Phase 2a clinical trial with HBV/HDV entry inhibitor Myrcludex BPavel Bogomolov,Natalia Voronkova,Lena Allweiss,Maura Dandri,Matthias Schwab,Florian A. Lempp,Mathias Haag,Heiner Wedemeyer,Alexander Alexandrov,Stephan UrbanHepatology(2014)引用 24|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要